NUK - logo

Rezultati iskanja

Osnovno iskanje    Izbirno iskanje   
Iskalna
zahteva
Knjižnica

Trenutno NISTE avtorizirani za dostop do e-virov NUK. Za polni dostop se PRIJAVITE.

1 2 3 4 5
zadetkov: 273
21.
Celotno besedilo
22.
  • COVID-19, SARS-CoV-2 Vaccin... COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections
    Maple, Peter A C Vaccines (Basel), 01/2023, Letnik: 11, Številka: 2
    Journal Article
    Recenzirano
    Odprti dostop

    There are several human herpesviruses. A common characteristic of infection by these viruses is latency, by which the virus assumes a non-replicative state, subverting the attentions of the host's ...
Celotno besedilo
23.
  • Hepatitis B and C virus rea... Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease
    Sansone, Stefano; Guarino, Maria; Castiglione, Fabiana ... World journal of gastroenterology : WJG, 04/2014, Letnik: 20, Številka: 13
    Journal Article
    Odprti dostop

    In recent years,a number of case reports and clinical studies have highlighted the risk of hepatitis B and C virus reactivation in patients with inflammatory bowel disease who are treated with ...
Celotno besedilo

PDF
24.
  • A randomised, single-blind,... A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes
    Keymeulen, Bart; van Maurik, André; Inman, Dave ... Diabetologia, 02/2021, Letnik: 64, Številka: 2
    Journal Article
    Recenzirano
    Odprti dostop

    Aims/hypothesis Numerous clinical studies have investigated the anti-CD3ɛ monoclonal antibody otelixizumab in individuals with type 1 diabetes, but limited progress has been made in identifying the ...
Celotno besedilo

PDF
25.
  • Overview of the immunologic... Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies
    Ma, Hui; Yan, Qing-Zhu; Ma, Jing-Ru ... World journal of gastroenterology : WJG, 03/2024, Letnik: 30, Številka: 10
    Journal Article
    Odprti dostop

    Hepatitis B virus (HBV) reactivation is a clinically significant challenge in disease management. This review explores the immunological mechanisms underlying HBV reactivation, emphasizing disease ...
Celotno besedilo
26.
  • Comparison of HBV reactivat... Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis
    He, Min-Ke; Peng, Chuan; Zhao, Yang ... Cancer Immunology, Immunotherapy, 11/2021, Letnik: 70, Številka: 11
    Journal Article
    Recenzirano

    Background Programmed cell death protein-1 (PD-1) inhibitor is recommended to treat advanced hepatocellular carcinoma (HCC). However, the safety of PD-1 inhibitor in patients with high HBV-DNA load ...
Celotno besedilo
27.
  • Postnatal Cytomegalovirus Infection Through Human Milk in Preterm Infants: Transmission, Clinical Presentation, and Prevention
    Hamprecht, Klaus; Goelz, Rangmar Clinics in perinatology, 03/2017, Letnik: 44, Številka: 1
    Journal Article
    Recenzirano

    Cytomegalovirus (CMV) is reactivated in the lactating breast in up to 96% of CMV seropositive mothers. There is a relevant entity of postnatally acquired symptomatic CMV infection and disease of ...
Preverite dostopnost
28.
  • Low Risk of Hepatitis B Vir... Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study
    Varisco, Valentina; Viganò, Mauro; Batticciotto, Alberto ... Journal of rheumatology, 05/2016, Letnik: 43, Številka: 5
    Journal Article
    Recenzirano
    Odprti dostop

    Patients with resolved hepatitis B virus (HBV) infection, i.e., hepatitis B surface antigen (HBsAg)-negative/antihepatitis B core antigen (anti-HBc)-positive, undergoing rituximab (RTX)-based ...
Celotno besedilo

PDF
29.
  • Hepatitis B virus reactivat... Hepatitis B virus reactivation with a rituximab-containing regimen
    Tsutsumi, Yutaka; Yamamoto, Yoshiya; Ito, Shinichi ... World journal of hepatology, 09/2015, Letnik: 7, Številka: 21
    Journal Article
    Odprti dostop

    Rituximab is currently used not only in the treatment of B-cell lymphoma but also for various other diseases, including autoimmune diseases, post-transplant graft vs host disease, and rejection ...
Celotno besedilo

PDF
30.
  • Resolved hepatitis B infect... Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
    Elsebaey, Mohamed A; Elbedewy, Tamer A; Elashry, Heba ... Medicine (Baltimore), 2022-Nov-25, 2022-11-25, 20221125, Letnik: 101, Številka: 47
    Journal Article
    Recenzirano
    Odprti dostop

    Risk of hepatitis B virus reactivation (HBVr) in patients with resolved HBV infection receiving immunosuppressive therapy has been a growing concern, particularly in the era of biological and ...
Celotno besedilo
1 2 3 4 5
zadetkov: 273

Nalaganje filtrov